Accession Number: | 0001104659-22-077703 |
Date: | 2022-07-01 |
Issuer: | ENTRADA THERAPEUTICS, INC. (TRDA) |
Original Submission Date: |
SETHURAMAN NATARAJAN
C/O ENTRADA THERAPEUTICS, INC.
6 TIDE STREET
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 12.0 | 2022-07-01 | deemed execution date | A | 34,763 (a) | 2032-07-01 | common stock 34,763 | $12.00 | 34,763 | direct |
ID | footnote |
---|---|
f1 | 25% of the option shares shall vest and become exercisable on july 1, 2023, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, such that the option shares will be fully vested on july 1, 2026. |